Fujitsu and Idenken Collaborate on Bio-Database

Jul 09, 2004


      Bookmark and Share

The National Institute of Genetics, also known as Idenken, and Fujitsu Limited have announced their agreement to collaborate on development of a next-generation database system. Aiming to develop a research and business platform for the post-genome era of biotechnology, an industry that is expected to reach 25 trillion yen by 2010, Idenken and Fujitsu plan to develop the world's fastest database system and position it as the de facto standard for the field.

The new system will be based on Fujitsu's Interstage Shunsaku Data Manager Enterprise Edition XML database engine. A previous prototype developed prior to this announcement has reportedly already achieved speeds 100 times faster than Idenken's existing database system. The prototype of this system will be installed at Idenken's Center for Information Biology and DNA Data Bank of Japan (CIB-DDBJ), and is scheduled to be publicly unveiled by the end of this year.

The CIB-DDBJ, together with the European Molecular Biology Laboratory and the U.S.'s National Institutes of Health, constitute the world's three major DNA databanks, with Japan's operated by the DNA Data Bank of Japan, which is constructing the world's largest repository of genomic and genetic data. The DDBJ stores on behalf of all Japan's government agencies the data from genome projects on numerous organisms, as well as publicly available data from the Patent Office, and is therefore positioned at the center of Japan's life sciences research.

Its database currently holds 35 million data including DNA pattern of 39.8 billion bases (equivalent to 200 years of newspapers), and continues to grow at an explosive rate-- doubling every year. With over 10,000 users accessing the database every day, a faster DNA database is the key for Idenken to capture and maintain the pole position in the fiercely competitive world of biotech R&D.

For its part in the project, Fujitsu is employing the platform technology of its advanced XML database engine, Interstage Shunsaku. This technology will be able to handle massive amounts of data and a huge volume of searches, all while delivering fast search performance, enabling immediate responses to users' varied search requests. Once it is completed, the system will not only allow more thorough research to be conducted than ever before, operating on the level of the body, organs, tissues, cells, and molecules, but it will also open the way to personalized medicine based on the latest research, which may be the key to curing cancer, high blood pressure, diabetes, and other diseases, as well as shortening the development cycle for new drugs.

www.fujitsu.com